Towards Healthcare
Non-Steroidal Anti-Inflammatory Drugs Market to Drive USD 37.73 Bn by 2035

Non-Steroidal Anti-Inflammatory Drugs Market Growth Driven by Innovation

Based on market forecasts, the global Non-steroidal anti-inflammatory drugs market, projected at USD 23.16 billion in 2025, is expected to reach USD 37.73 billion by 2035, growing at a CAGR of 5% over the forecast period. Arthritis dominated the NSAIDs market with a 38% share. Oral administration was the top choice (56%) for its ease of use. Retail pharmacies led distribution, holding 46% of the market. North America remained the largest market for NSAIDs, driving growth and demand in the sector.

Last Updated : 17 November 2025 Category: Therapeutic Area Insight Code: 5132 Format: PDF / PPT / Excel

Content

Introduction

  • Research Objective
  • Scope of the Study
  • Definition and Taxonomy

Research Methodology

  • Research Approach
  • Data Sources
  • Assumptions

Executive Summary

  • Synopsis
  • Analyst Recommendations

Market Overview 

  • Market Dynamics
    • Market Drivers
    • Market Restraints
    • Market Opportunities
  • Value Chain Analysis
    • Raw Material Sourcing
    • Manufacturing Process
    • Logistics & Transportation
    • Buyer Preferences
  • Trends
    • Market Trends
    • Technological Trends
  • Porter’s Five Forces Analysis
    • Bargaining Power of Suppliers
    • Bargaining Power of Buyers
    • Threat of Substitute
    • Threat of New Entrants
    • Degree of Competition
  • PESTLE Analysis for 5 Leading Countries
    • Regulatory Framework for Leading Countries/Regions
    • Supply Demand Analysis
    • Production & Consumption Statistics
    • Export Import Statistics
    • Price Trend Analysis

Global Cancer Vaccines Market Assessment

  • Overview
  • Global Cancer Vaccines Market Size Value (US$) and Volume (Billion Tons), by Disease Type (2021 – 2033)
    • Arthritis
    • Migraine
    • Ophthalmic Diseases
    • Others
  • Global Cancer Vaccines Market Size Value (US$) and Volume (Billion Tons), by Route of Administration (2021 – 2033)
    • Oral
    • Topical
    • Others
  • Global Cancer Vaccines Market Size Value (US$) and Volume (Billion Tons), by Distribution Channel (2021 – 2033)
    • Hospital Pharmacy
    • Retail Pharmacy
    • Online Pharmacy
  • Global Cancer Vaccines Market Size Value (US$) and Volume (Billion Tons), by Geography (2021 – 2033)
    • North America
    • Europe
    • Asia Pacific
    • Middle East and Africa
    • South America

North America Cancer Vaccines Market Assessment

  • Overview
  • North America Cancer Vaccines Market Size Value (US$) and Volume (Billion Tons), by Disease Type (2021 – 2033)
    • Arthritis
    • Migraine
    • Ophthalmic Diseases
    • Others
  • North America Cancer Vaccines Market Size Value (US$) and Volume (Billion Tons), by Route of Administration (2021 – 2033)
    • Oral
    • Topical
    • Others
  • North America Cancer Vaccines Market Size Value (US$) and Volume (Billion Tons), by Distribution Channel (2021 – 2033)
    • Hospital Pharmacy
    • Retail Pharmacy
    • Online Pharmacy

Europe Cancer Vaccines Market Assessment

  • Overview
  • Europe Cancer Vaccines Market Size Value (US$) and Volume (Billion Tons), by Disease Type (2021 – 2033)
    • Arthritis
    • Migraine
    • Ophthalmic Diseases
    • Others
  • Europe Cancer Vaccines Market Size Value (US$) and Volume (Billion Tons), by Route of Administration (2021 – 2033)
    • Oral
    • Topical
    • Others
  • Europe Cancer Vaccines Market Size Value (US$) and Volume (Billion Tons), by Distribution Channel (2021 – 2033)
    • Hospital Pharmacy
    • Retail Pharmacy
    • Online Pharmacy

Asia Pacific Cancer Vaccines Market Assessment

  • Overview
  • Asia Pacific Cancer Vaccines Market Size Value (US$) and Volume (Billion Tons), by Disease Type (2021 – 2033)
    • Arthritis
    • Migraine
    • Ophthalmic Diseases
    • Others
  • Asia Pacific Cancer Vaccines Market Size Value (US$) and Volume (Billion Tons), by Route of Administration (2021 – 2033)
    • Oral
    • Topical
    • Others
  • Asia Pacific Cancer Vaccines Market Size Value (US$) and Volume (Billion Tons), by Distribution Channel (2021 – 2033)
    • Hospital Pharmacy
    • Retail Pharmacy
    • Online Pharmacy

Middle East and Africa Cancer Vaccines Market Assessment

  • Overview
  • Middle East and Africa Cancer Vaccines Market Size Value (US$) and Volume (Billion Tons), by Disease Type (2021 – 2033)
    • Arthritis
    • Migraine
    • Ophthalmic Diseases
    • Others
  • Middle East and Africa Cancer Vaccines Market Size Value (US$) and Volume (Billion Tons), by Route of Administration (2021 – 2033)
    • Oral
    • Topical
    • Others
  • Middle East and Africa Cancer Vaccines Market Size Value (US$) and Volume (Billion Tons), by Distribution Channel (2021 – 2033)
    • Hospital Pharmacy
    • Retail Pharmacy
    • Online Pharmacy

South America Cancer Vaccines Market Assessment

  • Overview
  • South America Cancer Vaccines Market Size Value (US$) and Volume (Billion Tons), by Disease Type (2021 – 2033)
    • Arthritis
    • Migraine
    • Ophthalmic Diseases
    • Others
  • South America Cancer Vaccines Market Size Value (US$) and Volume (Billion Tons), by Route of Administration (2021 – 2033)
    • Oral
    • Topical
    • Others
  • South America Cancer Vaccines Market Size Value (US$) and Volume (Billion Tons), by Distribution Channel (2021 – 2033)
    • Hospital Pharmacy
    • Retail Pharmacy
    • Online Pharmacy

Company Profiles

  • Pfizer Inc.
    • Company Overview
    • Geographic Footprints
    • Financial Performance
    • Product Portfolio
    • SWOT Analysis
    • R&D Efforts
    • Recent Developments & Strategic Collaborations
      • Product Launch/M&A/Technical Collaboration
  • Merck & Co., Inc.
  • Novartis AG
  • GlaxoSmithKline Plc
  • Johnson & Johnson Services Inc.
  • Bayer AG
  • Dr. Reddy's Laboratories Ltd.
  • Viatris Inc
  • AstraZeneca
  • Abbott Laboratories

Conclusion & Recommendations

FAQ's

Answer : The NSAIDs market is projected to rise from USD 23.16 billion in 2025 to USD 24.32 billion in 2026 and reach USD 37.73 billion by 2035, driven by a steady 5% CAGR.

Answer : Arthritis remains the top contributor, capturing 38% of the market due to its high global prevalence, especially among aging adults.

Answer : NSAIDs are widely preferred over opioids because they effectively relieve pain with far lower addiction risks and fewer severe side effects.

Answer : The driving factors of non-steroidal anti-inflammatory drugs include their efficacy in managing pain and inflammation, widespread availability, and diverse applications across various medical conditions.

Answer : World Health Organization, Food and Drug Administration, National Institute of Health, ScienceDirect, PubMed.gov.
Any Questions

Meet the Team

Deepa Pandey is a focused and detail-oriented market research professional with growing expertise in the healthcare sector, delivering high-quality insights across therapeutic areas, diagnostics, biotechnology and healthcare services.

Learn more about Deepa Pandey

Aditi Shivarkar is a seasoned professional with over 14 years of experience in healthcare market research. As a content reviewer, Aditi ensures the quality and accuracy of all market insights and data presented by the research team.

Learn more about Aditi Shivarkar